22
Titel presentatie [Naam, organisatienaam] Working Day - Track: Modern cluster policy Dutch clusters on stage Ingrid Coninx, Hans Rijnten, Mirjam Mol & James Wilson Dutch clusters on stage

TCI 2016 Dutch clusters on stage

Embed Size (px)

Citation preview

Page 1: TCI 2016 Dutch clusters on stage

Titel presentatie[Naam, organisatienaam]

Working Day - Track: Modern cluster policyDutch clusters on stage

Ingrid Coninx, Hans Rijnten, Mirjam Mol & James Wilson

Dutch clusters on stage

Page 2: TCI 2016 Dutch clusters on stage

Dutch Clusters on Stage

Ingrid Coninx, Wageningen Environmental ResearchHans Rijnten, Economic Board UtrechtMirjam Mol, Pivot ParkJames Wilson, Orkestra – Basque Institute of Competitiveness

Page 3: TCI 2016 Dutch clusters on stage

Large variety

3

Page 4: TCI 2016 Dutch clusters on stage

TCI GLOBAL CONFERENCE 2016Dutch clusters on the stage

Hans Rijnten, Economic Board Utrecht

November 10, 2016

Page 6: TCI 2016 Dutch clusters on stage

Megatrend 2: Ageing population

Page 7: TCI 2016 Dutch clusters on stage

Megatrend 3: Digitalisation

Page 8: TCI 2016 Dutch clusters on stage

Economic Board UtrechtEconomic Research – our strenghts

Page 9: TCI 2016 Dutch clusters on stage

Economic Board UtrechtTriple helix partners

Page 10: TCI 2016 Dutch clusters on stage

• Societal challenge = economic opportunity

• Strategic agenda: o green economyo Life sciences & healtho Service innovation

• Private commitment (businesses)• Scalable• Reinforcement profile region

Economic Board UtrechtRegional agenda 2013-2020: Green, Healthy and Smart

Page 12: TCI 2016 Dutch clusters on stage

www.pivotpark.com

Pivot ParkThe ecosystem

Mirjam Mol10 November 2016

Page 13: TCI 2016 Dutch clusters on stage

● 13

Pivot Park is a unique park in the NetherlandsTHE place for innovative drug discovery research and development in the Netherlands: form target to market

Where chemistry and biology meet

Turn key facilities: state of the art laboratories, offices, completely furnished and equipped to start research or development activities

Unique core facilities: Modern equipment which is needed for biological, chemical and analytical lab research

two pilot plants

ultra high throughput screening facility with compound collection

R & D services (equipment / utilities / waste management) by a team of experts; customized solution for our customers

Cross-over Chemistry/Life Sciences

Page 14: TCI 2016 Dutch clusters on stage

History

Page 15: TCI 2016 Dutch clusters on stage

Analytics

HTSuHTSCompounds

Pilot Plants

Lab & Office facilities

• Fully equipped labs

• Open Access labs

• Flex labs

• Nuclear Magnetic Resonance

• Liquid Chromatography

• Mass Spectrometry

• Open Access HTS

• Flexible uHTS• Hit / Lead

optimization

• Up to 10 kg• GMP standard• Small

molecules• GMP/FDA

approved• Clinical trial

materials• Marketed

batches

Unieke faciliteiten, apparatuur, kennis en bedrijfsvoering

Page 16: TCI 2016 Dutch clusters on stage

Growth of the Pivot Park Community

Page 17: TCI 2016 Dutch clusters on stage

Pivot Park community (September 2016)

CROs

Product development

CMOs

Other services

Page 18: TCI 2016 Dutch clusters on stage

Pivot Park community – R&D pathway (September 2016)

Acerta PharmaAPO-TAduro Biotech EuropeGlycostemInnatOssLead PharmaLitevaxModiquestNTRCOsteo-PharmaSynAffi x

3D-PharmXchangeAUTHOR!BioAxisBioXpertInProcess-LSPPivot Park Screening CentreSpinnovation AnalyticalQuality by DesignQuantitative SolutionsQuintilesZwiers Regulatory

AspenBioConnection ChemConnection

Arnold+Siedsma BAM Infra StruktonBogaerts en Groenen CVIS Thema groepDotcombusiness ESP Van Oss GroepFriday Life Sciences Hulshof Kroonen & GroenEkoy Investment Partners Rescop

RegistrationTarget discovery

Leaddiscovery

Leadoptimization

Pre-clinical development

Clinical phase I

Clinical phase II

Clinical phase III

Largescale manufacturing

Page 19: TCI 2016 Dutch clusters on stage

Pivot Park CommunityBenefits of the ecosystem

• Inspiration by interaction• New opportunities for

collaboration• Diversity: from target to

market• Sharing high-end

facilities = cost reduction• Strong position in

regional, national and international knowledge infrastructure

Page 20: TCI 2016 Dutch clusters on stage

Main trend in innovative entrepreneurship worldwide!

Facilitating open innovation

Closed innovatio

n

Open innovatio

n

From closed …

• Solo-creation• Transactions• IP legal drive• Academic research

funding by industry

• Large enterprises determine market access for innovation

… to open innovation:

• Co-creation• Networks/

Relationships• Entrepreneurial

drive• Commercial &

Academic research collaboration

• SMEs accelerate market access in innovation

Page 21: TCI 2016 Dutch clusters on stage

Screening consortiaTKI Oncodrugs

TargetID HTS Hit

OptimisationLead Optimisation

DevelopmentCandidate

Clinical Development

Identification and development of compounds for different targets • NKI, NTRC, Covalution BioSciences and Lead Pharma targets• PPSC High Throughput Screening using their compound library• Leids Instituut voor Chemie (LIC) MedChem (in close collaboration with PPSC)• NKI testing • Lead Pharma, Covalution BioSciences and NTRC MedChem, H2L and LO

Objective: Find lead series/clinical candidates in the field of oncology and interest from big pharma

Covalution BioSciences

Page 22: TCI 2016 Dutch clusters on stage